Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Pediatric Blood & Cancer|June 24, 2025
Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic LeukemiaKrunal Shah, Harish Tandra, Ulrike Loebel, et al.
Hemasphere|September 28, 2020
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic LeukemiaClemence Virely, Luca Gasparoli, Maurizio Mangolini, et al.
British Journal of Haematology|April 2, 2005
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trialAnindita Roy, Mike Bradburn, Anthony V Moorman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working groupLeiah J Brigitha, Marta Fiocco, Rob Pieters, et al.
British Journal of Haematology|September 26, 2022
Mixed chimerism post haematopoietic stem cell transplantation in JMML: Interventions and outcomeMaria Gabelli, Milena Balasch-Carulla, Anupama Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2017
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic LeukemiaDavid O'Connor, Amir Enshaei, Jack Bartram, et al.
Blood Advances|July 2, 2025
Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centreDaniela Guardo, Avijeet Kumar Mishra, Hebatalla Rashed, et al.
Genes, Chromosomes & Cancer|May 3, 2021
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemiaThomas Creasey, Amir Enshaei, Karin Nebral, et al.
British Journal of Haematology|April 17, 2004
The London Cord Blood Bank: analysis of banking and transplantation outcomeSue Davey, Sue Armitage, Vanderson Rocha, et al.
Science Translational Medicine|October 26, 2022
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemiaGiorgio Ottaviano, Christos Georgiadis, Soragia Athina Gkazi, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Pediatric Blood & Cancer|June 24, 2025
Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic LeukemiaKrunal Shah, Harish Tandra, Ulrike Loebel, et al.
Hemasphere|September 28, 2020
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic LeukemiaClemence Virely, Luca Gasparoli, Maurizio Mangolini, et al.
British Journal of Haematology|April 2, 2005
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trialAnindita Roy, Mike Bradburn, Anthony V Moorman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working groupLeiah J Brigitha, Marta Fiocco, Rob Pieters, et al.
British Journal of Haematology|September 26, 2022
Mixed chimerism post haematopoietic stem cell transplantation in JMML: Interventions and outcomeMaria Gabelli, Milena Balasch-Carulla, Anupama Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2017
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic LeukemiaDavid O'Connor, Amir Enshaei, Jack Bartram, et al.
Blood Advances|July 2, 2025
Long term outcomes of genome edited 'universal' CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centreDaniela Guardo, Avijeet Kumar Mishra, Hebatalla Rashed, et al.
Genes, Chromosomes & Cancer|May 3, 2021
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemiaThomas Creasey, Amir Enshaei, Karin Nebral, et al.
British Journal of Haematology|April 17, 2004
The London Cord Blood Bank: analysis of banking and transplantation outcomeSue Davey, Sue Armitage, Vanderson Rocha, et al.
Science Translational Medicine|October 26, 2022
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemiaGiorgio Ottaviano, Christos Georgiadis, Soragia Athina Gkazi, et al.
Pageof 17